The story of the successful management of disseminated testicular cancer (TC) is well known and is listed among the American Society of Clinical Oncology’s top five accomplishments in cancer medicine in the last 50 years.^1,2 Using the development of highly active systemic chemotherapy as a backbone, global outcomes achieved in experienced centers or collaborative groups are unparalleled. Now, many patients presenting with TC receive no therapy beyond orchiectomy. Those who do present with or develop more advanced disease are most often rendered disease free with inexpensive, relatively brief treatments. More than 95% of all patients are cured and most enjoy high-quality, long-term survivorship.

中文翻译：

---

实践变得完美：睾丸癌的其余故事作为可治愈的模型肿瘤

成功治疗弥漫性睾丸癌（TC）的故事是众所周知的，并且被列为美国临床肿瘤学会在过去50年中在癌症医学方面的前五名成就。^1,2以高活性全身化疗的发展为骨干，在经验丰富的中心或协作小组中取得的全球成果是无与伦比的。现在，许多表现为TC的患者除了睾丸切除术外没有其他治疗方法。那些确实患有或发展为晚期疾病的人最常通过廉价，相对简短的治疗使疾病无病。超过95％的患者已治愈，并且大多数患者享有高质量的长期存活率。